Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams

被引:24
作者
Spangler, SK
Jacobs, MR
Appelbaum, PC
机构
[1] PENN STATE UNIV, MILTON S HERSHEY MED CTR, DEPT PATHOL, HERSHEY, PA 17033 USA
[2] CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA
关键词
D O I
10.1093/jac/39.2.141
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Broth MIC and time-kill methodology was used to determine the activity of cefditoren relative to those of penicillin G, ampicillin, amoxycillin, WY-49605, cefuroxime, cefpodoxime, cefdinir, cefixime and cefaclor against three penicillin-susceptible, three intermediate and three penicillin-resistant pneumococci. MICs of all agents rose with those of penicillin G. Cefditoren was the most active agent (MICs 0.002-0.5 mg/L), followed by WY-49605 (0.008-1.0 mg/L), amoxycillin (0.015-2.0 mg/L), cefuroxime (0.015-4.0 mg/L), cefpodoxime (0.03-4.0 mg/L), ampicillin (0.015-8.0 mg/L), cefdinir (0.03-16.0 mg/L), cefixime (0.125-64.0 mg/L) and cefaclor (0.5-128.0 mg/L). All beta-lactams were bactericidal at the MIC after 24 h, and produced 90% killing after 12 h at concentrations above the MIC. Bactericidal concentrations of cefditoren, even for penicillin-resistant strains, were less than or equal to 0.5 mg/L at 24 h. Additionally, cefditoren and WY-49605 were the only compounds that killed 99% of all strains after 6 h at greater than or equal to 4 x MIC. Cefditoren and amoxycillin killed 90% of all strains at 8 x MIC, and WY-49605 at 4 x MIC, after 4 h. Ampicillin had time-kill kinetics similar to those of amoxycillin, but MICs were 1-2 dilutions higher than the latter drug. Cefuroxime and cefpodoxime were the most active of other oral cephalosporins tested. Cefditoren and WY-49605 had the lowest MICs and most favourable time-kill kinetics of all beta-lactams tested.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 29 条
[1]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[2]   EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].
BREIMAN, RF ;
BUTLER, JC ;
TENOVER, FC ;
ELLIOTT, JA ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835
[3]  
CANTON R, 1994, 34 INT C ANT AG CHEM, P28
[4]  
Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P23
[5]  
FREMAUX A, 1993, 18TH INT C CHEM, P289
[6]  
FREMAUX A, 1992, 32ND INT C ANT AG CH, P280
[7]   MANAGEMENT OF PENICILLIN-RESISTANT PNEUMOCOCCAL INFECTIONS [J].
FRIEDLAND, IR ;
ISTRE, GR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (06) :433-435
[8]  
FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
[9]  
GOTO S, 1991, 31 INT C ANT AG CHEM, P236
[10]   THE PREVALENCE OF DRUG-RESISTANT STREPTOCOCCUS-PNEUMONIAE IN ATLANTA [J].
HOFMANN, J ;
CETRON, M ;
FARLEY, MM ;
BAUGHMAN, WS ;
FACKLAM, RR ;
ELLIOTT, JA ;
DEAVER, KA ;
BREIMAN, RF .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (08) :481-486